Acrivon Therapeutics ACRV
- prexasertib — Endometrial Cancer Phase 2
- ACR-368 — Squamous Cell Carcinoma of the Head and Neck Phase 2
CHK1 (1 companies · 2 programs)
Companies with an active program directed at CHK1.
Companies with an active program directed at CHK1.